Our Team

Nakul Shankar, MD
COO, and Co-Founder of Syntheslide

Nakul is a physician who trained at Ross University School of Medicine. He conceptualized Syntheslide's whole slide imaging protocols during the spare time of his third and fourth year rotations in Medical School. He has relied on the mentorship and guidance of many attending pathologists along the way while rotating as a doctor in training in many different cities.

Austin McCarty
CEO and Co-Founder of Syntheslide

Austin is currently a Technical Program Manager at Amazon, delivering Alexa Custom Assistant to large OEMs such as BMW and Honda. Previously, he was a full-time developer and architect with General Motors. He architected changes and developed the back end for their Mobile App (RemoteLink) and in-vehicle IHUs (Infotainment Head Units). He has a BS in COmputer Sciences from MSU and MBA from Ross School of Business & University of Michigan. On the side, he founded an independent gaming company and enjoys running as a hobby. He recently completed the Detroit Free Press marathon.

Kirk Wojno, MD
CSO of Syntheslide

Doctor Wojno is a nationally renowned expert in prostate biopsy interpretation. He studied at The Johns Hopkins hospital in the 1990s and was trained by the father of modern urologic pathology, Doctor Jonathan Epstein. As the former head of urologic pathology at the University of Michigan, St. John’s Health System , and national Ameripath laboratories he is extremely knowledgeable in his field.

Donald Moylan, MD
CEO of Syntheslide

Presently, Dr. Moylan is the President and CEO of Comprehensive Urology and Comprehensive Medical Center, PLLC. This group offers patients the best integrated Urologic healthcare in the state of Michigan. The main office building on Woodward is the best equipped and staffed Urologic Center in the State of Michigan. Dr. Moylan is also one of the founders of the Beaumont Oncology Network, Beaumont Hospital’s Cancer care program involving all three Beaumont Hospitals. He is also one of the leaders in the country in formulating Oncology Best Practice Plans and Quality Collaboratives to provide patients the best diagnosis and treatment of their Urologic disorder.